GAVI & Sania Nishtar

GAVI: GAVI>>> is the global vaccine alliance that had its funding from the United States>>> pulled, but is now expected to see a resumption of funding, which will enable it to continue its work on vaccine distribution and outbreak response.

Sania Nishtar: Sania Nishtar>>>, GAVI>>>'s chief executive, expressed encouragement regarding the United States>>>' re-engagement and emphasized the importance of unlocking congressional funds for global health security.

GAVI: GAVI co-published the analysis on African immunization, emphasizing the life-saving power of vaccines and the need for continued efforts to reach all children.

Sania Nishtar: Sania Nishtar, CEO of GAVI, highlighted the life-saving power of vaccines and acknowledged the need for more work to reach children in fragile and remote contexts.

GAVI: Gavi receives $600 million in released funds, resumes U.S. board seat, and commits to vaccine safety reforms, strengthening its financial position and global immunization programs.

Sania Nishtar: Gavi's CEO announced the alliance's move away from mercury-containing vaccines and expressed gratitude for resumed U.S. support.

GAVI: GAVI, the global vaccine alliance, reports that lower-income countries contributed a record $302 million towards vaccines in 2025, promoting co-financing as a key pillar for predictable health funding.

Sania Nishtar: Sania Nishtar, GAVI chief executive, states that co-financing creates predictability in health funding, contrasting it with reliance on aid for basic services.

GAVI: GAVI, a partner in vaccination efforts with the World Health Organization, is experiencing a financial crunch, further threatening immunization programs in Africa.

Sania Nishtar: Sania Nishtar, chief executive of GAVI, emphasized the need to reach children in fragile and remote contexts, acknowledging the varied realities of immunization outcomes.

GAVI: Making its RVSV-ZEBOV vaccine stockpile available for trials and supporting vaccine access. Its role is key in ensuring vaccine availability for the response.

Sania Nishtar: CEO of GAVI, warning the outbreak could become the largest ever. Her statements highlight the severity.

GAVI: GAVI>>> holds a stockpile of Ebola vaccines and has 2,000 doses already in the Democratic Republic of the Congo>>> for potential trial use.

Sania Nishtar: Sania Nishtar>>>, chief executive of GAVI>>>, confirmed the availability of vaccine doses in the Democratic Republic of the Congo>>>.